论文部分内容阅读
目的:对抗结核规定剂量复合剂每日与隔日不同服药方式治疗新发肺结核的疗效进行分析。方法:随机选取我院2015年12月-2016年12月所收治的96例肺结核患者作为主要研究对象,并按照每日治疗和隔日治疗分别将患者分为观察组与对照组各48例,对两种不同服药方式的疗效及在治疗过程中所产生的不良反应进行对比分析。结果:观察组患者的胃肠道、神经系统等不良反应发生率明显低于对照组,差异具有统计学意义(P<0.05)。结论:抗结核固定剂量复合剂每日服药方式对控制肺结核具有重要作用,可确保患者在短时间内恢复身体健康,值得临床推广。
OBJECTIVE: To analyze the curative effect of treating tuberculosis with new-onset tuberculosis daily and every other day by taking the prescribed dose of TB compound. Methods: A total of 96 patients with pulmonary tuberculosis who were treated in our hospital from December 2015 to December 2016 were selected as the main study subjects. Patients were divided into observation group and control group according to daily treatment and every other day treatment. The efficacy of the two different modes of administration and the adverse reactions generated during the course of treatment were analyzed comparatively. Results: The adverse reactions such as gastrointestinal tract and nervous system in the observation group were significantly lower than those in the control group (P <0.05). Conclusion: The daily dosage of anti-tuberculosis fixed-dose compound plays an important role in the control of pulmonary tuberculosis, which can ensure that patients recover their health in a short time and deserve clinical promotion.